Welcome to
On Feet Nation
Meghna Kaur Online
Lovina Lindy Online
Theresa Online
Smith Online
Linda Online
Amelia Cruz Online
Binda JD Online
Posted by Lovina Lindy on April 26, 2024 at 3:00am 0 Comments 0 Likes
Amidst the raging second wave of the COVID-19 pandemic and many fearing a third wave, the healthcare sector is in the limelight for the second consecutive year as several pharma and life sciences companies are lined up to tap the equity markets through IPOs over the next few months, according to investment bankers.
Five such companies which have firmed up their initial public offering (IPO) plans are Glenmark Lifesciences, a fully-owned arm of Glenmark Pharmaceuticals, the city-based bulk drugs firm Supriya Lifesciences, drug formulations firm Windlass Biotech, Bain Capital-backed Emcure Pharma and CX Partners-funded Veeda Clinical Research.
Read more athttps://www.business-standard.com/article/markets/glenmark-arm-emcu...
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation